跳至主要内容
临床试验/CTRI/2020/06/025939
CTRI/2020/06/025939进行中(未招募)未知

â??Comparative Study on the effect of Esomeprazole and Ranitidine on the bioavailability and Efficacy of Mycophenolic acid in Scleroderma patientsâ??.

Centre for Arthritis and Rheumatism Excellence CARE0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Ba/be

入排标准

入选标准

  • Scleroderma diagnosed with ACR criteria
  • Scleroderma patients on a stable dose of MMF for more than 2 months ( 1.5- 3 gm/day )

排除标准

  • Co medication with cholestyramine, magnesium or aluminium containing antacids and rifampicin
  • Patients on high dose of corticoteroids( >.5mg/kg)
  • GFR < 30ml/min
  • HIV HCV, HBV â?? Positive
  • End stage lung disease
  • Those who have documented Gastro duodenal ulce

研究者

发起方
Centre for Arthritis and Rheumatism Excellence CARE

相似试验